Artificial Tears

Treatment for Dry Eye Disease

Typical Dosage: 1-6+ drops daily as needed

Effectiveness
50%
Safety Score
90%
Clinical Trials
235
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
90
DangerousModerateSafe
Treatment Details
Dosage Range
1-6+ drops daily as needed
Time to Effect
immediate
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$100
Side Effect Mgmt:$0
Total Annual:$600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.01
Outcome-Based Costs
Cost per Responder
$706
Cost per Remission
$30,000
Artificial Tears Outcomes

for Dry Eye Disease

Efficacy Outcomes
Overall Effectiveness
+50%
Response Rate
+85%
Remission Rate
+2%
Common Side Effects
Transient blurred vision
+1%
Mild irritation
+0.5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Artificial Tears in Dry Eye Disease

Efficacy of Lipid-containing Artificial Tears in the Treatment of Dry Eye

NCT06955585NOT YET RECRUITINGNA
View Study
50 participants
INTERVENTIONAL
Zagreb, Croatia
Started: Apr 25, 2025

CG-101 Eye Drops in the Treatment of Dry Eye Syndrome

NCT06792903RECRUITINGEARLY_PHASE1
View Study
30 participants
INTERVENTIONAL
Shanghai, China
Started: Apr 23, 2024

Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE

NCT06913387ACTIVE NOT RECRUITINGNA
View Study
60 participants
INTERVENTIONAL
Lahore, Pakistan
Started: Mar 20, 2025

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.

NCT06939959RECRUITINGPHASE4
View Study
126 participants
INTERVENTIONAL
Peshawar, Pakistan
Started: Apr 14, 2025
Completed Clinical Trials
11 completed trials for Artificial Tears in Dry Eye Disease

Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears

NCT01614847COMPLETEDPHASE4
View Study
8 participants
INTERVENTIONAL
Tahlequah, United States
Started: Jun 1, 2012

Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study

NCT06726525COMPLETEDPHASE4
View Study
44 participants
INTERVENTIONAL
Messina, Italy
Started: Feb 3, 2024

Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye

NCT06752278COMPLETEDNA
View Study
40 participants
INTERVENTIONAL
Damietta, Egypt
Started: Oct 1, 2024

A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

NCT06544694COMPLETEDPHASE3
View Study
79 participants
INTERVENTIONAL
Louisville, United States +3 more
Started: Oct 8, 2024

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel

NCT03697876COMPLETEDPHASE1
View Study
32 participants
INTERVENTIONAL
Mexico City, Mexico
Started: Aug 20, 2018

Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease

NCT04668131COMPLETEDNA
View Study
20 participants
INTERVENTIONAL
Beijing, China +1 more
Started: Sep 22, 2020

A Natural History Study of Patients With Dry Eye

NCT00833235COMPLETED
View Study
284 participants
OBSERVATIONAL
Little Rock, United States +16 more
Started: Feb 1, 2009

Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation

NCT04633863COMPLETEDNA
View Study
24 participants
INTERVENTIONAL
Lucca, Italy
Started: Oct 12, 2020

The Visual Effect of an Investigational Artificial Tear in the Tear Layer.

NCT00395759COMPLETEDNA
View Study
30 participants
INTERVENTIONAL
Fullerton, United States
Started: Sep 1, 2005

Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease

NCT05896670COMPLETEDPHASE2
View Study
122 participants
INTERVENTIONAL
Newport Beach, United States +4 more
Started: Nov 29, 2023

Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

NCT02051023COMPLETEDPHASE3
View Study
41 participants
INTERVENTIONAL
Valladolid, Spain +1 more
Started: Feb 1, 2014
Showing 20 of 239 total trials